Both subgroups were comparable concerning hemodynamic parameters (mean arterial pressure, central venous pressure), but non-survivors showed an increased heart rate and received more vasoactive medication (norepinephrine) to maintain sufficient circulation.
The effect size in the more susceptible subgroups was comparable for both markers at lag 0, although not significant for CD80, but was much higher for CD80 than for CD40 at lags 2 and 3.
In the population "vascular intracranial hypertension" the two subgroups were comparable.
This means that only persistent AFib subgroups were comparable, and these groups were not different indeed.
Analysis revealed that the three OAI subgroups were comparable for all rehabilitation outcomes studied.
The two subgroups were comparable in most clinical parameters except radiation therapy (20% v 40.5%, p = 0.037).
Furthermore, we found that the incidence of silent lacunar infarcts in permanent and latent RLS subgroups was comparable with non-shunt RLS subgroup (28.6% versus 24% versus 21.3%, P > 0.05).
As can be seen in Table 1, the two preterm subgroups were comparable to one another in terms of birth weight, F 1, 31) = 0.28, p =.60, and gestational age, F 1, 31) = 0.001, p =.98.
One could argue that the activity documented in platinum-resistant and relatively sensitive subgroups is comparable to the amount of responses reported for platinum reinduction in these specific populations [ 5, 7, 30- 32].
Although most subgroups were comparable on most characteristics, differences were found between the LogMAR visual acuity subgroups, where patients with low vision/blindness significantly more often received assistance by someone to fill out the questionnaire (68%) than patients with mild vision loss (52%; p = 0.006).
